Retension Pharmaceutical

Falls Church, VA · Founded 2023 · Privately Held (backing)

Developer of therapeutic drugs designed for patients with hypertension. Retension Pharmaceutical is based in Falls Church, VA and was founded in 2023. Its last reported valuation was $50 million in May 2025. It has raised $22.4 million.

Last reported valuation

$50.0M

Oct 2026

Priced at

—

Total raised

$22.4M

Last round

—

How much has Retension Pharmaceutical raised?

$22.4Macross 0 recorded rounds

Free account

More of Retension Pharmaceutical with a free account

·Watch Retension Pharmaceutical: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Retension Pharmaceutical investors

4 investors are on record for Retension Pharmaceutical, including Dais Partners, Collage Venture Partners, Green Park & Golf Ventures and Transhuman Capital.

For fundraisers

Raising for a company like Retension Pharmaceutical?

4 investors have backed Retension Pharmaceutical.

See all 4 investors →

Frequently asked about Retension Pharmaceutical

How much has Retension Pharmaceutical raised?: Retension Pharmaceutical has raised $22.4M in total across 0 recorded funding rounds.